The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Next Generation Sequencing (NGS) Solution Market Research Report 2024
Synopsis
Next Generation Sequencing (NGS), also known as high-throughput sequencing, refers to advanced genomic technologies that enable the rapid and cost-effective sequencing of DNA or RNA molecules. NGS solutions have revolutionized the field of genomics and have significant applications in various areas of life sciences, including medical research, diagnostics, personalized medicine, agriculture, and environmental studies.
Global Next Generation Sequencing (NGS) Solution market is projected to reach US$ 10060 million in 2029, increasing from US$ 3690 million in 2022, with the CAGR of 15.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Sequencing (NGS) Solution market research.
The global market for Next Generation Sequencing (NGS) solutions has experienced significant growth in recent years, driven by the increasing adoption of NGS technologies in various research and clinical applications. NGS has revolutionized genomics research, personalized medicine, and diagnostics, making it one of the most impactful technologies in the life sciences industry. Continuous innovations in NGS platforms, sequencing chemistries, and bioinformatics tools have improved sequencing accuracy, speed, and data analysis capabilities. The increasing focus on understanding the genetic basis of diseases, population genomics, and agricultural genomics has driven the demand for NGS solutions. The United States and Canada are major contributors to the global NGS market due to their well-established research infrastructure and a large number of NGS-based research projects. European countries, including the United Kingdom, Germany, and France, have seen significant NGS adoption in both research and clinical applications. Countries like China, Japan, and India have witnessed rapid growth in the NGS market, driven by increasing research investments and government initiatives. The global market for NGS solutions is expected to continue its growth trajectory in the coming years. The increasing adoption of NGS in clinical diagnostics, precision medicine, and agriculture is likely to drive further market expansion. Moreover, ongoing advancements in NGS technologies, such as single-cell sequencing and long-read sequencing, will continue to unlock new research possibilities and applications, expanding the reach of NGS into various scientific disciplines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Next Generation Sequencing (NGS) Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eurofins Scientific
Illumina
PerkinElmer
Thermo Fisher Scientific
Roche Holding
Agilent Technologies
Myriad Genetics
Foundation Medicine
Oxford Nanopore Technologies
Pacific Biosciences
Paradigm Diagnostics
BGI Group
Caris Life Sciences
Partek
Natera
LabCorp
Macrogen
Genotypic Technology
Segment by Type
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing and Resequencing Centrifuges
Segment by Application
Sporadic Cancer
Inherited Cancer
Companion Diagnostics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Sequencing (NGS) Solution report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Next Generation Sequencing (NGS), also known as high-throughput sequencing, refers to advanced genomic technologies that enable the rapid and cost-effective sequencing of DNA or RNA molecules. NGS solutions have revolutionized the field of genomics and have significant applications in various areas of life sciences, including medical research, diagnostics, personalized medicine, agriculture, and environmental studies.
Global Next Generation Sequencing (NGS) Solution market is projected to reach US$ 10060 million in 2029, increasing from US$ 3690 million in 2022, with the CAGR of 15.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Sequencing (NGS) Solution market research.
The global market for Next Generation Sequencing (NGS) solutions has experienced significant growth in recent years, driven by the increasing adoption of NGS technologies in various research and clinical applications. NGS has revolutionized genomics research, personalized medicine, and diagnostics, making it one of the most impactful technologies in the life sciences industry. Continuous innovations in NGS platforms, sequencing chemistries, and bioinformatics tools have improved sequencing accuracy, speed, and data analysis capabilities. The increasing focus on understanding the genetic basis of diseases, population genomics, and agricultural genomics has driven the demand for NGS solutions. The United States and Canada are major contributors to the global NGS market due to their well-established research infrastructure and a large number of NGS-based research projects. European countries, including the United Kingdom, Germany, and France, have seen significant NGS adoption in both research and clinical applications. Countries like China, Japan, and India have witnessed rapid growth in the NGS market, driven by increasing research investments and government initiatives. The global market for NGS solutions is expected to continue its growth trajectory in the coming years. The increasing adoption of NGS in clinical diagnostics, precision medicine, and agriculture is likely to drive further market expansion. Moreover, ongoing advancements in NGS technologies, such as single-cell sequencing and long-read sequencing, will continue to unlock new research possibilities and applications, expanding the reach of NGS into various scientific disciplines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Next Generation Sequencing (NGS) Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eurofins Scientific
Illumina
PerkinElmer
Thermo Fisher Scientific
Roche Holding
Agilent Technologies
Myriad Genetics
Foundation Medicine
Oxford Nanopore Technologies
Pacific Biosciences
Paradigm Diagnostics
BGI Group
Caris Life Sciences
Partek
Natera
LabCorp
Macrogen
Genotypic Technology
Segment by Type
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing and Resequencing Centrifuges
Segment by Application
Sporadic Cancer
Inherited Cancer
Companion Diagnostics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Sequencing (NGS) Solution report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing (NGS) Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Whole Genome Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Targeted Sequencing and Resequencing Centrifuges
1.3 Market by Application
1.3.1 Global Next Generation Sequencing (NGS) Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Sporadic Cancer
1.3.3 Inherited Cancer
1.3.4 Companion Diagnostics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing (NGS) Solution Market Perspective (2018-2029)
2.2 Next Generation Sequencing (NGS) Solution Growth Trends by Region
2.2.1 Global Next Generation Sequencing (NGS) Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Next Generation Sequencing (NGS) Solution Historic Market Size by Region (2018-2023)
2.2.3 Next Generation Sequencing (NGS) Solution Forecasted Market Size by Region (2024-2029)
2.3 Next Generation Sequencing (NGS) Solution Market Dynamics
2.3.1 Next Generation Sequencing (NGS) Solution Industry Trends
2.3.2 Next Generation Sequencing (NGS) Solution Market Drivers
2.3.3 Next Generation Sequencing (NGS) Solution Market Challenges
2.3.4 Next Generation Sequencing (NGS) Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing (NGS) Solution Players by Revenue
3.1.1 Global Top Next Generation Sequencing (NGS) Solution Players by Revenue (2018-2023)
3.1.2 Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Players (2018-2023)
3.2 Global Next Generation Sequencing (NGS) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing (NGS) Solution Revenue
3.4 Global Next Generation Sequencing (NGS) Solution Market Concentration Ratio
3.4.1 Global Next Generation Sequencing (NGS) Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Solution Revenue in 2022
3.5 Next Generation Sequencing (NGS) Solution Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing (NGS) Solution Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing (NGS) Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing (NGS) Solution Breakdown Data by Type
4.1 Global Next Generation Sequencing (NGS) Solution Historic Market Size by Type (2018-2023)
4.2 Global Next Generation Sequencing (NGS) Solution Forecasted Market Size by Type (2024-2029)
5 Next Generation Sequencing (NGS) Solution Breakdown Data by Application
5.1 Global Next Generation Sequencing (NGS) Solution Historic Market Size by Application (2018-2023)
5.2 Global Next Generation Sequencing (NGS) Solution Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
6.2 North America Next Generation Sequencing (NGS) Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Next Generation Sequencing (NGS) Solution Market Size by Country (2018-2023)
6.4 North America Next Generation Sequencing (NGS) Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
7.2 Europe Next Generation Sequencing (NGS) Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2018-2023)
7.4 Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
8.2 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
9.2 Latin America Next Generation Sequencing (NGS) Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Next Generation Sequencing (NGS) Solution Market Size by Country (2018-2023)
9.4 Latin America Next Generation Sequencing (NGS) Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
10.2 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Detail
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Introduction
11.1.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.1.5 Eurofins Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Next Generation Sequencing (NGS) Solution Introduction
11.2.4 Illumina Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.2.5 Illumina Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Next Generation Sequencing (NGS) Solution Introduction
11.3.4 PerkinElmer Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.3.5 PerkinElmer Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Introduction
11.4.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche Holding
11.5.1 Roche Holding Company Detail
11.5.2 Roche Holding Business Overview
11.5.3 Roche Holding Next Generation Sequencing (NGS) Solution Introduction
11.5.4 Roche Holding Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.5.5 Roche Holding Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Detail
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Introduction
11.6.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.6.5 Agilent Technologies Recent Development
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Detail
11.7.2 Myriad Genetics Business Overview
11.7.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Introduction
11.7.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.7.5 Myriad Genetics Recent Development
11.8 Foundation Medicine
11.8.1 Foundation Medicine Company Detail
11.8.2 Foundation Medicine Business Overview
11.8.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Introduction
11.8.4 Foundation Medicine Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.8.5 Foundation Medicine Recent Development
11.9 Oxford Nanopore Technologies
11.9.1 Oxford Nanopore Technologies Company Detail
11.9.2 Oxford Nanopore Technologies Business Overview
11.9.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Introduction
11.9.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.9.5 Oxford Nanopore Technologies Recent Development
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Detail
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Introduction
11.10.4 Pacific Biosciences Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.10.5 Pacific Biosciences Recent Development
11.11 Paradigm Diagnostics
11.11.1 Paradigm Diagnostics Company Detail
11.11.2 Paradigm Diagnostics Business Overview
11.11.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Introduction
11.11.4 Paradigm Diagnostics Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.11.5 Paradigm Diagnostics Recent Development
11.12 BGI Group
11.12.1 BGI Group Company Detail
11.12.2 BGI Group Business Overview
11.12.3 BGI Group Next Generation Sequencing (NGS) Solution Introduction
11.12.4 BGI Group Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.12.5 BGI Group Recent Development
11.13 Caris Life Sciences
11.13.1 Caris Life Sciences Company Detail
11.13.2 Caris Life Sciences Business Overview
11.13.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Introduction
11.13.4 Caris Life Sciences Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.13.5 Caris Life Sciences Recent Development
11.14 Partek
11.14.1 Partek Company Detail
11.14.2 Partek Business Overview
11.14.3 Partek Next Generation Sequencing (NGS) Solution Introduction
11.14.4 Partek Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.14.5 Partek Recent Development
11.15 Natera
11.15.1 Natera Company Detail
11.15.2 Natera Business Overview
11.15.3 Natera Next Generation Sequencing (NGS) Solution Introduction
11.15.4 Natera Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.15.5 Natera Recent Development
11.16 LabCorp
11.16.1 LabCorp Company Detail
11.16.2 LabCorp Business Overview
11.16.3 LabCorp Next Generation Sequencing (NGS) Solution Introduction
11.16.4 LabCorp Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.16.5 LabCorp Recent Development
11.17 Macrogen
11.17.1 Macrogen Company Detail
11.17.2 Macrogen Business Overview
11.17.3 Macrogen Next Generation Sequencing (NGS) Solution Introduction
11.17.4 Macrogen Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.17.5 Macrogen Recent Development
11.18 Genotypic Technology
11.18.1 Genotypic Technology Company Detail
11.18.2 Genotypic Technology Business Overview
11.18.3 Genotypic Technology Next Generation Sequencing (NGS) Solution Introduction
11.18.4 Genotypic Technology Revenue in Next Generation Sequencing (NGS) Solution Business (2018-2023)
11.18.5 Genotypic Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
